StockWatch
·
Biological Products, (No Diagnostic Substances)
AGM/EGMNov 18, 2026, 08:31 AM

AIM ImmunoTech Adjourns 2026 Annual Meeting to December 8

AI Summary

AIM ImmunoTech Inc. announced the adjournment of its 2026 Annual Meeting of Stockholders, originally scheduled for November 17, 2026, to December 8, 2026. The adjournment was necessary due to a lack of sufficient shares present or represented by proxy to constitute a quorum, with approximately 32.5% of outstanding shares having submitted proxies. The meeting will continue to be held virtually, and the record date for voting remains September 28, 2026. No changes have been made to the proposals being voted on.

Key Highlights

  • AIM ImmunoTech Inc. adjourned its 2026 Annual Meeting of Stockholders.
  • The meeting is rescheduled to December 8, 2026, at 11:00 A.M. Eastern Time.
  • A quorum was not met, with only 32.5% of shares represented by proxy.
  • The meeting will continue to be held in a virtual format.
  • The record date for voting remains September 28, 2026.